DOI QR코드

DOI QR Code

A Study on the Correlations between Total Prostate Volume and Prostate Transition Zone Volume Assessed Using Blood and Ultrasound Tests: in the Healthy Korean Men in Thirties

혈액, 초음파 검사 결과를 이용한 전립선이행대용적의 상관관계 연구: 기초질환이 없는 30대를 대상으로

  • Kim, Sang-Hyun (Department of Radiological Science, Shinhan University)
  • 김상현 (신한대학교 방사선학과)
  • Received : 2017.08.24
  • Accepted : 2017.10.31
  • Published : 2017.10.31

Abstract

This study investigates the correlations between the total prostate volume (TPV), using the prostate specific antigen (PSA) and prostate specific antigen density (PSAD) as the blood test results and transrectal ultrasound (TRUS), and the prostate transition zone volume (PTZV), as well as variables such as age; the findings can be used as clinical indicators. A retrospective analysis was conducted on 68 healthy men in their 30s who underwent TRUS and PSA and PSAD blood tests from June 2007 to April 2016, with no history of treatment in their prostate. Siemens Acuson sequoia 512 and the probe Siemens EC-10C5 Endocavitary were used as the ultrasound equipment. For statistical analysis, SPSS 18.0 was used to calculate the standard deviation and mean of each variable; Pearson's correlation analysis was also performed. The descriptive statistics of the variables were $24.27{\pm}6.60$ for TPV, $6.99{\pm}6.60$ for PTZV, $2.12{\pm}2.76$ for PSA, and $0.281{\pm}0.1$ for PSAD. The coefficients of correlations between PTZV and variables were 0.831 for PSAD, 0.707 for TPV, 0.398 for age, and 0.118 for PSA. While PSA and age were positively correlated, PSAD and TPV were highly correlated. Therefore, PTZV of men in their 30s without underlying diseases can be predicted using PSAD and TPV.

본 연구는 혈액 검사 결과인 전립선특이항원(PSA) 및 전립선특이항원밀도 (PSAD), 전립선 경직장 초음파 (TRUS)를 이용한 전립선 전체용적 (TPV), 나이등 변수와 전립선이행대용적 (PTZV)과 상관관계를 연구하여 임상적 지표로 활용하고자 한다. 2007년 6월부터 2016년 4월 까지 전립선에 대한 치료력이 없는 건강한 30대 성인 남성으로 TRUS와 PSA, PSAD 혈액 검사를 실시한 총 68명을 후향적으로 분석하였다. 초음파 장비는 Siemens Acuson sequoia 512)와 탐촉자 Siemens EC~10C5 Endocavitary를 이용하였다. 통계 처리의 경우, SPSS 18.0 각 변수와 표준 편차의 평균을 계산하는 데 사용하고, 피어슨 상관관계 분석을 수행 하였다. 변수들의 기술 통계량은 TPV; $24.27{\pm}6.60$, PTZV; $6.99{\pm}6.60$, PSA; $2.12{\pm}2.76$와 PSAD; $0.281{\pm}0.1$이고. 전립선 이행용적과 변수의 상관 계수는 PSAD; 0.831, TPV; 0.707, 나이; 0.398, 그리고 PSA; 0.118이었다. PSA 및 연령과의 양의 크기의 상관관계지만, PSAD, TPV가 높은 상관관계를 보였다. 따라서, 기저 질환이 없는 30대 남성의 PTZV는 TPV와 PSAD를 통해 예측할 수 있다.

Keywords

References

  1. Y. M. Kim, J. Y. Jeong, D. K. Han, "Prostate Volume Measurement by Transrectal Ultrasonography in the Healthy Korean Men in Thirties", Journal of the Korea Contents Association, Vol. 12, No. 6, pp.339-345, 2012. https://doi.org/10.5392/JKCA.2012.12.02.348
  2. H. T. Kim, P. H. Song, G. H. Moon, "The Clinical Significance of Transrectal Ultrasonography, Prostate-specific Antigen and Prostate-specific Antigen Density for the Reduction of Unnecessary Biopsies", Korean Journal of Andrology, Vol. 26, No. 3, pp.147-152, 2008.
  3. Nickel JC, Roehrbon CG, O Leary MP, "The Relationship between Prostate Inflammation and Lower Urinary Tract Symptoms: Examination of Baseline Data from the Reduce Trial", European Urology, Vol. 54, No. 6, pp.1379-1384, 2007. https://doi.org/10.1016/j.eururo.2007.11.026
  4. Cotran S, Kumar V, Collins T, "Prostate in the malegenital tract". In Robbins Pathologic basis of disease 6th ed. Philadelphia", Saunders Company, pp.1025-1033, 1999.
  5. Freedland J, Moul J, "Prostate Specific Antigen recurrence after definitive Therapy", Journal of Urology, Vol. 177, No. 6, pp.1985-1991, 2007. https://doi.org/10.1016/j.juro.2007.01.137
  6. S. B. Kim, J. Y. Chung, Y. G. Seo, "An Average Shape Model for Segmenting Prostate Boundary of TRUS Prostate Image", Journal of Information Processing Systems, Vol. 3, No. 5, pp.187-194, 2014.
  7. Dahnert W, "Determination of prostate volume with transrectal US for cancer screening", Radiology, Vol.183, No. 3, pp.625-627, 1992. https://doi.org/10.1148/radiology.183.3.1584907
  8. G. N. Collins, G. M. Raab, M. Hehir, B. King and W. M. Garraway, "Reproducibility and observer variability of transrectal ultrasound measurements of prostatic volume", ultrasound in Medicine & Biology, Vol.21, No. 9, pp.1101-1105, 1995. https://doi.org/10.1016/0301-5629(95)02001-2
  9. B. Y. Jeong, S. U. Yoon, J. I. Kim, S. S. Park, "Correlations between Prostate Transition Zone Index and Clinical Parameters of Benign Prostatic Hyperplasia", Inje Medical Journal, Vol. 23, No. 3, 2002.
  10. S. H. Seol, Y. W. Park, J. Y. Park, "Study of Prostate of Korean Young Adult Using Transrectal Ultrasonography", Korean Journal of Urology, Vol. 49, No. 8, pp.720-725, 2008. https://doi.org/10.4111/kju.2008.49.8.720
  11. D. U. Kim, H. R. Lee, W. J. Kim, "Prostatic Size Variation with Age: Randomized Community-based Survey in Chungbuk Province", Korean Journal of Urology, Vol. 39, No. 8, pp.762-765, 1998.
  12. S. E. Lee, D. Y. Kim, C. K, "Interrelationship among Age Prostate Specific Antigen and prostate Volume in Korean Men Living at the Metropolitan Area", Korean Journal of Urology, Vol. 40, No. 10, pp.1311-1317, 1999.
  13. R. J. Glynn, E. W. Campion, G. R. Bouchard, and J. E. Silbert, "The development of benign prostatic hyperplasia among volunteers in the normative aging study", American Journal of Epidemiology, Vol. 121, No. 1, pp.78-90, 1985.
  14. Green DR, Egawa S, Hellerstein DK, Scarrdino PT, "Sonographic measurements of transition zone of prostate in men and without benign prostatic hyperplasia", Urology, Vol. 36, No. 4, pp.293-296, 1990. https://doi.org/10.1016/0090-4295(90)80231-B
  15. Y. Zhan and D. Shen, "Deformable Segmentation of 3-D Ultrasound Prostate Images Using Statistical Texture Matching Method", IEEE Transactions on Medical Imaging, Vol. 25, No. 3, pp.256-272, 2006. https://doi.org/10.1109/TMI.2005.862744
  16. A. Rafiee, A. Salimi, and A. Roostam, "A Novel Prostate Segmentation Algorithm in TRUS Images", World Academy of Science, Engineering and Technology, Vol. 45, No. 1, pp.120-124, 2008.
  17. Barry MJ, "Clinical practice Prostatic-specific antigen testing for early diagnosis of prostate cancer", New England Journal Medicine, Vol. 344, No. 18, pp.1373-1377, 2001. https://doi.org/10.1056/NEJM200105033441806
  18. I. C. Cho, S. K. Min, "Inflammation of prostate and prostate-specific antigen", The Korean Journal of Urogenital Tract Infect and Inflammation, Vol. 10, No.1, pp.7-11, 2015. https://doi.org/10.14777/kjutii.2015.10.1.7
  19. Stamey TA, Caldwell M, McNeal JE, Nolley R, Hemenez M, Downs J, "The prostate specific antigen era in the United States is over for prostate cancer: What happened in the last 20 years", Journal of Urology, Vol. 172, No. 4, pp.1297-1301, 2004. https://doi.org/10.1097/01.ju.0000139993.51181.5d
  20. Polascik TJ, Oesterling JE, Partin AW, "Prostate specific antigen: a decade of discovery-What we have learned and where we are going", Journal of Urology, Vol. 162, No. 2, pp.293-306, 1999. https://doi.org/10.1016/S0022-5347(05)68543-6